Related references
Note: Only part of the references are listed.Development and validation of reassigned CEA, CYFRA21-1 and NSE-based models for lung cancer diagnosis and prognosis prediction
Jingmin Yuan et al.
BMC CANCER (2022)
Artificial intelligence for breast cancer detection in mammography and digital breast tomosynthesis: State of the art
Ioannis Sechopoulos et al.
SEMINARS IN CANCER BIOLOGY (2021)
The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer
Yitian Xu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients
Lei Chen et al.
CELL RESEARCH (2021)
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
Karina W. Davidson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
E. A. Klein et al.
ANNALS OF ONCOLOGY (2021)
Development of a panel of autoantibody against NSG1 with CEA, CYFRA21-1, and SCC-Ag for the diagnosis of esophageal squamous cell carcinoma
Qingzhu Zheng et al.
CLINICA CHIMICA ACTA (2021)
Artificial Intelligence in Colorectal Cancer Screening, Diagnosis and Treatment. A New Era
Athanasia Mitsala et al.
CURRENT ONCOLOGY (2021)
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
Anne Marie Lennon et al.
SCIENCE (2020)
Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer
Hai Luo et al.
ONCOLOGY LETTERS (2020)
Value of AFP and PIVKA-II in diagnosis of HBV-related hepatocellular carcinoma and prediction of vascular invasion and tumor differentiation
Yuan-Quan Si et al.
INFECTIOUS AGENTS AND CANCER (2020)
Identifying occult maternal malignancies from 1.93 million pregnant women undergoing noninvasive prenatal screening tests
Xing Ji et al.
GENETICS IN MEDICINE (2019)
Genome-wide cell-free DNA fragmentation in patients with cancer
Stephen Cristiano et al.
NATURE (2019)
Machine learning enables detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNA
Nathan Wan et al.
BMC CANCER (2019)
Screening for Prostate Cancer US Preventive Services Task Force Recommendation Statement
David C. Grossman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer
Yanfeng Gao et al.
SCIENTIFIC REPORTS (2018)
Serum CA72-4 as a biomarker in the diagnosis of colorectal cancer: A meta-analysis
Han Yanqing et al.
OPEN MEDICINE (2018)
Screening for Cervical Cancer US Preventive Services Task Force Recommendation Statement
Susan J. Curry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer
Weigang Wang et al.
CLINICA CHIMICA ACTA (2017)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement
Albert L. Siu et al.
ANNALS OF INTERNAL MEDICINE (2016)
CEA in breast ductal secretions as a promising biomarker for the diagnosis of breast cancer: a systematic review and meta-analysis
Shifu Tang et al.
BREAST CANCER (2016)
Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy
Yu-Lei Gu et al.
Asian Pacific Journal of Cancer Prevention (2015)
Cancer screening through a multi-analyte serum biomarker panel during health check-up examinations: Results from a 12-year experience
Ying-Hao Wen et al.
CLINICA CHIMICA ACTA (2015)
Estimation of savings of life-years and cost from early detection of cervical cancer: a follow-up study using nationwide databases for the period 2002-2009
Mei-Chuan Hung et al.
BMC CANCER (2014)
Development of serum parameters panels for the early detection of pancreatic cancer
Pengjun Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The challenge of intratumour heterogeneity in precision medicine
J. Seoane et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Multitarget Stool DNA Testing for Colorectal-Cancer Screening
Thomas F. Imperiale et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy
Zhipeng Sun et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2014)
Combined use of AFP, CEA, CA125 and CA19-9 improves the sensitivity for the diagnosis of gastric cancer
Chao-Zhu He et al.
BMC GASTROENTEROLOGY (2013)
Tumor Markers in Clinical Practice: A Review Focusing on Common Solid Cancers
Michael J. Duffy
MEDICAL PRINCIPLES AND PRACTICE (2013)
An overview of biomarkers for the ovarian cancer diagnosis
Bei Zhang et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2011)
Symptoms of hepatocellular carcinoma. Laboratory tests used for its diagnosis and screening
Judit Gervain
ORVOSI HETILAP (2010)
CA125 in ovarian cancer
Nathalie Scholler et al.
BIOMARKERS IN MEDICINE (2007)
Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125
Ben Van Calster et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Detection of carcinomas in an asymptomatic Chinese population: Advantage of screening with multiple tumor markers
KC Tsao et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2006)
Share Paper
